This inventor holds 1 USPTO granted patent. Top assignee: Virbac Sa. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Christine Branger: Innovator in Leptospirosis Treatment
Introduction
Christine Branger is a notable inventor based in Vertou, France. She has made significant contributions to the field of veterinary and human medicine, particularly in the prevention and treatment of leptospirosis. Her innovative work has the potential to impact both animal and human health.
Latest Patents
Christine Branger holds a patent for "Peptides for preventing, diagnosing and treating animal and/or human leptospirosis." This invention provides a compound chosen from a peptide represented by the sequence SEQ ID No: 1. Her research focuses on developing effective solutions to combat this serious disease.
Career Highlights
Branger is associated with Virbac S.A., a company dedicated to animal health. Her role at Virbac has allowed her to work on groundbreaking research that addresses critical health issues. With her expertise, she has contributed to advancing the understanding and treatment of leptospirosis.
Collaborations
Christine has collaborated with notable colleagues, including André Aubert and Benoît Chatrenet. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.
Conclusion
Christine Branger's work exemplifies the importance of innovation in addressing health challenges. Her contributions to the field of leptospirosis treatment highlight her role as a leading inventor in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile